Clinical Trials in Daegu, Dalseo gu
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
A 24-week rPMS Study in Real-world Setting for Enerzair
Asthma
Novartis Pharmaceuticals600 enrolled20 locationsNCT05274425
Recruiting
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Asthma
Novartis Pharmaceuticals600 enrolled18 locationsNCT05217810
Recruiting
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Graft-Versus-Host Disease
Novartis Pharmaceuticals127 enrolled11 locationsNCT05621733
Recruiting
A Post Marketing Surveillance on Piqray in Korea
Breast Cancer
Novartis Pharmaceuticals900 enrolled17 locationsNCT05293470